Qube Research & Technologies (QRT)
CLSD

Qube Research & Technologies (QRT)’s Clearside Biomedical CLSD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$5 – 3414
2024
Q2 		– Sell
-360
Closed -$6.96K – 3650
2024
Q1 		$8.27K Buy
+360
New +$7.76K ﹤0.01% 3826
2023
Q4 		– Hold
0
– – – 4207
2023
Q3 		– Hold
0
– – – 3985
2021
Q4 		– Sell
-1,721
Closed -$155K – 2578
2021
Q3 		$155K Buy
+1,721
New +$152K ﹤0.01% 1714
2021
Q2 		– Sell
-1,214
Closed -$45K – 2324
2021
Q1 		$45K Sell
1,214
-4,907
-80% -$246K ﹤0.01% 1784
2020
Q4 		$252K Sell
6,121
-1,167
-16% -$30.3K ﹤0.01% 1432
2020
Q3 		$168K Buy
7,288
+4,671
+178% +$121K ﹤0.01% 1435
2020
Q2 		$74K Buy
+2,617
New +$77.1K ﹤0.01% 1554

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGH
GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLSD Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Clearside Biomedical (CLSD) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3414.

Qube Research & Technologies (QRT) first reported a position in CLSD in Q2 2020 and has held it in 6 quarters since. The position peaked at $252K in Q4 2020. 48 funds tracked by Wall St. Rank hold CLSD as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Clearside Biomedical worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Clearside Biomedical share count unchanged in Q3 2024.
  • Clearside Biomedical made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #3414 holding.
  • Qube Research & Technologies (QRT) first reported a position in Clearside Biomedical in Q2 2020 and has held it in 6 quarters since.
  • Qube Research & Technologies (QRT)'s Clearside Biomedical position peaked at $252K in Q4 2020.
  • 48 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.